Correction to: Disruption of hypoxia-inducible fatty acid binding protein 7 induces beige fat-like differentiation and thermogenesis in breast cancer cells.

Journal

Cancer & metabolism
ISSN: 2049-3002
Titre abrégé: Cancer Metab
Pays: England
ID NLM: 101607582

Informations de publication

Date de publication:
2020
Historique:
entrez: 14 8 2020
pubmed: 14 8 2020
medline: 14 8 2020
Statut: epublish

Résumé

[This corrects the article DOI: 10.1186/s40170-020-00219-4.].

Identifiants

DOI: 10.1186/s40170-020-00224-7 PMID: 32789015 PMC: PMC7418190
pubmed: 32789015
doi: 10.1186/s40170-020-00224-7
pii: 224
pmc: PMC7418190
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

18

Commentaires et corrections

Type : ErratumFor

Informations de copyright

© The Author(s) 2020.

Références

Cancer Metab. 2020 Jul 6;8:13
pubmed: 32647572

Auteurs

Masahiro Kawashima (M)

Department of Oncology, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS UK.
Department of Breast Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, 606 8507 Japan.

Karim Bensaad (K)

Department of Oncology, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS UK.

Christos E Zois (CE)

Department of Oncology, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS UK.

Alessandro Barberis (A)

Department of Oncology, Computational Biology and Integrative Genomics Lab, CRUK/MRC Institute for Radiation Oncology, University of Oxford, Old Road Campus Research Building, Roosvelt Drive, Oxford, OX3 7DQ UK.

Esther Bridges (E)

Department of Oncology, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS UK.

Simon Wigfield (S)

Department of Oncology, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS UK.

Christoffer Lagerholm (C)

Wolfson Imaging Centre, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS UK.

Ruslan I Dmitriev (RI)

School of Biochemistry and Cell Biology, University College Cork, Cavanagh Pharmacy Building, 1.28, College Road, Cork, Ireland.
Institute for Regenerative Medicine, I.M. Sechenov First Moscow State University, Moscow, Russian Federation.

Mariko Tokiwa (M)

Department of Breast Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, 606 8507 Japan.

Masakazu Toi (M)

Department of Breast Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, 606 8507 Japan.

Dmitri B Papkovsky (DB)

School of Biochemistry and Cell Biology, University College Cork, Cavanagh Pharmacy Building, 1.28, College Road, Cork, Ireland.

Francesca M Buffa (FM)

Department of Oncology, Computational Biology and Integrative Genomics Lab, CRUK/MRC Institute for Radiation Oncology, University of Oxford, Old Road Campus Research Building, Roosvelt Drive, Oxford, OX3 7DQ UK.

Adrian L Harris (AL)

Department of Oncology, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS UK.

Classifications MeSH